Product Reports Resources Pricing Login Book a demo

SomaLogic

Biotech & Life Sciences · Boulder, United States · Founded 2000 · Public via SPAC 2021

Unlocking protein biomarkers to transform healthcare

Revenue $82M

Investors

26 investors on SomaLogic's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
ProQuest Investments
dRx Capital
Series B+ 24 investors entered at this stage
University of Colorado Boulder
Associates
Casdin Capital
Redmile Group
Novartis
Boston Millennia Partners
Monashee Investment Management
Logos Capital
Otsuka Pharmaceutical
Janus Henderson Investors
Amgen
Foresite Capital
Farallon Capital Management
iCarbonX
Millennium Management
T. Rowe Price
Madryn Asset Management
Nec
Quest Diagnostics
Reimagined Ventures
Soleus Capital
Intermountain Ventures
Ziff Capital Partners
Revelation Partners

Global footprint

Where SomaLogic has talent and traffic

Workforce by country
14 countries with
team presence
🇺🇸 United States89.8%
🇬🇧 United Kingdom1.8%
🇸🇬 Singapore1%
🇯🇵 Japan0.8%
🇫🇷 France0.7%
Top 5 of 14 shown
Web traffic by country
16K monthly visits
across markets
🇺🇸 United States61.3%
🇬🇧 United Kingdom11.3%
🇨🇦 Canada9.4%
🇮🇳 India6.3%
🇦🇺 Australia5%
Top 5 markets shown

Talent graph

The shape of SomaLogic's talent

Dealroom maps SomaLogic's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 standout operatorsDealroom-flagged across the org
5 AI specialistsincl. 2 core researchers
143 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock SomaLogic's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$140M patent portfolio · 82 active families

Estimated portfolio value
$140M
50.8× smaller than top peer Janssen Vaccines ($7.1B)
82 active patent families
Where SomaLogic innovates AptamerBiochemistryBioinformaticsBiologic markerBiophysics

Where SomaLogic concentrates vs peers

Each axis is a top-10 topic across SomaLogic and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about SomaLogic

An AI-synthesized read of the highest-engagement posts about SomaLogic on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SomaLogic on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.